Dec 10, 2021 / 01:00PM GMT
Operator
Good morning, and welcome to Moderna's conference call. (Operator Instructions) Please be advised that the call is being recorded.
At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please go ahead.
Lavina Talukdar - Moderna, Inc. - Senior VP & Head of IR
Thank you, operator. Good morning, everyone, and thank you for joining us on today's call to discuss Phase I interim analyses from our first seasonal flu program, mRNA-1010. You can access the press release issued this morning as well as the slides that we will be reviewing by going to the Investors section of our website. On today's call are Stephane Bancel, our Chief Executive Officer; Stephen Hoge, our President; and Jackie Miller, Senior Vice President, Head of Infectious Disease.
Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and our
Moderna Inc to Discuss Phase 1 Interim Analysis for mRNA Flu Vaccine - Conference Call Transcript
Dec 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers